final posted 2025 09 18 508

MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP)
Agenda

Cent
ers for Disease Control and Prevention
Atlanta, GA

Thursday, September 18, 2025
10:00 AM  Welcome and Roll Call  Dr. Martin Kulldorff (ACIP Chair)
Dr. Mina Zadeh (ACIP Executive Secretary, CDC)
10:30 AM  Update on Work Groups  Dr. Martin Kulldorff (ACIP Chair)

10:40  AM Measles, Mumps, Rubella, and Varicella
(MMRV) Vaccines
 Introduction  Dr. Martin Kulldorff (ACIP Chair)
 Background on MMRV  Dr. Arjun Srinivasan (CDC/NCIRD)
 Presentation on febrile seizure following
MMRV vaccine  Dr. John Su (CDC/NCEZID)
 MMRV  Vaccine Manufacturer Statements  TBD
 Proposed recommendations  and discussion  Dr. Martin Kulldorff (ACIP Chair)
 VFC presentation  Dr. Jeanne Santoli (CDC/NCIRD)

12:35  PM Lunch
1:05 PM Hepatitis B Vaccine
 Introduction  Dr. Martin Kulldorff (ACIP Chair)
 Presentation on Hepatitis B Birth Dose
Vaccination  Dr. Adam Langer (CDC/NCHHSTP)
 Hep B vaccine safety updates  Dr. John Su (CDC/NCEZID)
 Hep B  Vaccine Manufacturer Statements  TBD
 Proposed recommendations and discussion  Dr. Martin Kulldorff (ACIP Chair)
 VFC presentation  Dr. Jeanne Santoli (CDC/NCIRD)

3:55 PM Break

4:10 PM Agency Updates  CDC, CMS, FDA, HRSA, IHS, NIH

4:30 PM  Public Comment

5:00 PM  Votes

MMRV vaccines  Dr. Martin Kulldorff (ACIP Chair)
 MMRV vaccines - VFC  Dr. Jeanne Santoli (CDC/NCIRD)
Hepatitis B vaccines  Dr. Martin Kulldorff (ACIP Chair)
 Hepatitis B vaccines – VFC  Dr. Jeanne Santoli (CDC/NCIRD)

5:30 PM  Adjourn

MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP)
Agenda

Friday, September 19, 2025
8:30 AM  Welcome and Roll Call  Dr. Martin Kulldorff (ACIP Chair)
Dr. Mina Zadeh (ACIP Executive Secretary, CDC)

8:40 AM COVID -19 Vaccines
 Introduction  Dr. Retsef Levi (ACIP WG Chair)
 COVID -19 epidemiology update  Dr. Arjun Srinivasan (CDC/NCIRD)
 Updates to 2024 -2025 COVID -19
Implementation Considerations  Dr. Arjun Srinivasan (CDC/NCIRD)
 COVID -19 vaccine effectiveness update  Dr. Arjun Srinivasan (CDC/NCIRD)
 COVID -19 vaccine safety update  Dr. John Su (CDC/NCEZID)

10:05 AM  Break

10:10 AM  COVID -19 Vaccines (continued)
 Workgroup Safety Uncertainties of mRNA
COVID Vaccines  Dr. Wafik El -Deiry & Dr. Charlotte Kuperwasser
(COVID -19 Workgroup Member)
 Genomics of Vaccine -Induced Myocarditis  Dr. Bruce Carleton (COVID -19 Workgroup Member)
 Economic analysis of COVID -19 vaccination  Dr. Arjun Srinivasan (CDC/NCIRD) on behalf of the
University of Michigan
 COVID -19 Vaccine Manufacturer Statements  TBD

11:40 AM  Lunch

12:00 PM  COVID -19 Vaccines (continued)
 COVID -19 Discussion Framing  Dr. Retsef Levi (ACIP WG Chair)
Proposed recommendations and discussion  Dr. Retsef Levi (ACIP WG Chair)

1:40 PM  Break

1:45 PM  Public Comment

2:15 PM  Votes

COVID -19 Vaccines  Dr. Retsef Levi (ACIP WG Chair)

3:00 PM  Adjourn

Acronyms
CDC Centers for Disease Control and Prevention
CMS Centers for Medicare & Medicaid Services
COVID-19 Coronavirus disease 2019
FDA Food and Drug Administration
HRSA Health Resources and Services Administration
IHS Indian Health Service MMRV Measles, Mumps, Rubella, Varicella Vaccine NCIRD National Center for Immunization & Respiratory Diseases
NCEZID National Center for Emerging and Zoonotic Diseases  NCHHSTP National Center for HIV , Viral Hepatitis, STD, and Tuberculosis Prevention NIH National Institutes of Health
VFC Vaccines for Children

Summary: MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP)   Agenda    Cent ers for Disease Control and Prevention  Atlanta, GA     Thursday, September 18, 2025      10:00 AM  Welcome and Roll Call  Dr. Martin Kulldorff (ACIP Chair)   Dr. Mina Zadeh (ACIP Executive Secretary, CDC)      10:30 AM  Update on Work Groups  Dr. Martin Kulldorff (ACIP Chair)       10:40  AM Measles, Mumps, Rubella, and Varicella  (MMRV) Vaccines     Introduction  Dr. Martin Kulldorff (ACIP Chair)   …


final posted 2025 09 17 508

MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZA TION PRACTICES
(ACIP) Agenda (Final)
Centers for Disease Cont rol and Prevention
Atlanta, GA
Thursday, September 18, 2025
10:00 AM  Welcome and Roll Call  Dr. Martin Kulldorff (ACIP Chair)
Dr. Mina Zadeh (ACIP Executive Secretary, CDC)
10:30 AM  Update on Work Groups  Dr. Martin Kulldorff (ACIP Chair)
10:40  AM Measles, Mumps, Rubella, and Varicella
(MMRV) Vaccines
Introduction  Dr. Martin Kulldorff (ACIP Chair)
Background on MMRV  Dr. Arjun Srinivasan (CDC/NCIRD)
Presentation on febrile seizure following
MMRV vaccine  Dr. John Su (CDC/NCEZID)
MMRV  Vaccine Manufacturer Statements  TBD
Proposed recommendations  and discussion  Dr. Martin Kulldorff (ACIP Chair)
12:35  PM Lunch
1:05 PM Hepatitis B Vaccine
Introduction  Dr. Martin Kulldorff (ACIP Chair)
Presentation on Hep atitis  B Birth Dose
Vaccination  Dr. Adam Langer  (CDC/NCHHSTP)
Hep B vaccine safety updates  Dr. John Su (CDC/NCEZID)
Hep B  Vaccine Manufacturer Statements  TBD
Proposed recommendations  and discussion  Dr. Martin Kulldorff (ACIP Chair)
3:55 PM Break
4:10 PM Agency Updates  CDC, CMS, FDA, HRSA, IHS, NIH
4:30 PM Public Comment
5:00 PM Votes
MMRV vaccines  Dr. Martin Kulldorff (ACIP Chair)
MMRV vaccines - VFC  Dr. Jeanne Santoli (CDC/NCIRD)
Hepatitis B vaccines  Dr. Martin Kulldorff (ACIP Chair)
Hepatitis B vaccines – VFC  Dr. Jeanne Santoli (CDC/NCIRD)
5:30 PM  Adjourn
MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP)
Agenda (Draft)

Friday, September 19, 2025
8:30 AM  Welcome and Roll Call  Dr. Martin Kulldorff (ACIP Chair)
Dr. Mina Zadeh (ACIP Executive Secretary, CDC)

8:40 AM COVID -19 Vaccines
 Introduction  Dr. Retsef Levi (ACIP WG Chair)
 COVID -19 epidemiology update  Dr. Arjun Srinivasan (CDC/NCIRD)
 Updates to 2024 -2025 COVID -19
Implementation Considerations  Dr. Arjun Srinivasan (CDC/NCIRD)
 COVID -19 vaccine effectiveness update  Dr. Arjun Srinivasan (CDC/NCIRD)
 COVID -19 vaccine safety update  Dr. John Su (CDC/NCEZID)

10:05 AM  Break

10:10 AM  COVID -19 Vaccines (continued)
 Workgroup Safety Uncertainties of mRNA
COVID Vaccines  Dr. Wafik El -Deiry  & Dr. Charlotte Kuperwasser
(COVID -19 Workgroup Member)
 Genomics of Vaccine -Induced Myocarditis  Dr. Bruce Charleton (COVID -19 Workgroup Member)
 Economic analysis of COVID -19 vaccination  Dr. Arjun Srinivasan (CDC/NCIRD) on behalf of the
University of Michigan
 COVID -19 Vaccine Manufacturer Statements  TBD

11:40 AM  Lunch

12:00 PM  COVID -19 Vaccines (continued)
 COVID -19 Discussion Framing  Dr. Retsef Levi (ACIP WG Chair)
Proposed recommendations and discussion  Dr. Retsef Levi (ACIP WG Chair)

1:40 PM  Break

1:45 PM  Public Comment

2:15 PM  Votes

COVID -19 Vaccines  Dr. Retsef Levi (ACIP WG Chair)

3:00 PM  Adjourn

Acronyms
CDC Centers for Disease Control and Prevention
CMS Centers for Medicare & Medicaid Services
COVID -19 Coronavirus disease 2019
FDA Food and Drug Administration
HRSA Health Resources and Services Administration
IHS Indian Health Service
MMRV Measles, Mumps, Rubella, Varicella Vaccine
NCIRD National Center for Immunization & Respiratory Diseases
NCEZID National Center for Emerging and Zoonotic Diseases
NCHHSTP National Center for HIV , Viral Hepatitis, STD, and Tuberculosis Prevention
NIH National Institutes of Health
VFC Vaccines for Children

Summary: MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZA TION PRACTICES  (ACIP) Agenda (Final)   Centers for Disease Cont rol and Prevention   Atlanta, GA  Thursday, September 18, 2025   10:00 AM  Welcome and Roll Call  Dr. Martin Kulldorff (ACIP Chair)   Dr. Mina Zadeh (ACIP Executive Secretary, CDC)    10:30 AM  Update on Work Groups  Dr. Martin Kulldorff (ACIP Chair)  10:40  AM Measles, Mumps, Rubella, and Varicella  (MMRV) Vaccines   Introduction  Dr. Martin Kulldorff (ACIP Chair)   Background on…


draft posted 2025 09 12 508

MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP)
Agenda (Draft)

Centers for D
isease Con trol and Prevention
Atlanta, GA

Thursday, September 18, 2025
10:00 AM  Welcome and Roll Call  Dr. Martin Kulldorff (ACIP Chair)
Dr. Mina Zadeh (ACIP Executive Secretary, CDC)
10:30 AM  Update on Work Groups  Dr. Martin Kulldorff (ACIP Chair)

11:00 AM  Measles, Mumps, Rubella, and Varicella
(MMRV) Vaccines
 Introduction  Dr. Martin Kulldorff (ACIP Chair)
 Background on MMRV  Dr. Arjun Srinivasan (CDC/NCIRD)
 Presentation on febrile seizure following
MMRV vaccine  Dr. John Su (CDC/NCEZID)
 Proposed recommendations  and discussion  Dr. Martin Kulldorff (ACIP Chair)

1:00 PM  Lunch
1:30 PM Hepatitis B Vaccine
 Introduction  Dr. Martin Kulldorff (ACIP Chair)
 Presentation on Hep atitis  B Birth Dose
Vaccination  Dr. Adam Langer  (CDC/NCHHSTP)
 Hep B vaccine safety updates  Dr. John Su (CDC/NCEZID)
 Proposed recommendations  and discussion  Dr. Martin Kulldorff (ACIP Chair)

4:00 PM Break

4:15 PM Agency Updates  CDC, CMS, FDA, HRSA, IHS, NIH

4:30 PM Public Comment

5:00 PM Votes

MMRV vaccines  Dr. Martin Kulldorff (ACIP Chair)
 MMRV vaccines - VFC  Dr. Jeanne Santoli (CDC/NCIRD)
Hepatitis B vaccines  Dr. Martin Kulldorff (ACIP Chair)
 Hepatitis B vaccines – VFC  Dr. Jeanne Santoli (CDC/NCIRD)

5:30 PM  Adjourn

MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP)
Agenda (Draft)

Friday, September 19, 2025
8:30 AM  Welcome and Roll Call  Dr. Martin Kulldorff (ACIP Chair)
Dr. Mina Zadeh (ACIP Executive Secretary, CDC)

8:45 AM  COVID -19 Vaccines
 Introduction  Dr. Retsef Levi (ACIP WG Chair)
 COVID -19 epidemiology update  Dr. Arjun Srinivasan (CDC/NCIRD)
 Updates to 2024 -2025 COVID -19 Implementation
Considerations  Dr. Arjun Srinivasan (CDC/NCIRD)
 COVID -19 vaccine effectiveness update  Dr. Arjun Srinivasan (CDC/NCIRD)
 COVID -19 vaccine safety update  Dr. John Su (CDC/NCEZID)
 Additional COVID -19 vaccine safety  presentations   TBD

11:30  AM Lunch

12:00 PM COVID -19 Vaccines (continued)
 Economic analysis of COVID -19 vaccination  Dr. Arjun Srinivasan (CDC/NCIRD) on behalf of
the University of Michigan
 COVID -19 Vaccine Manufacturer update s TBD
 COVID -19 Discussion Framing  Dr. Retsef Levi (ACIP WG Chair)
Proposed recommendations  and discussion  Dr. Retsef Levi (ACIP WG Chair)

1:40 PM  Break

1:45 PM  Public Comment

2:15 PM  Votes

COVID -19 Vaccines  Dr. Retsef Levi (ACIP WG Chair)

3:00 PM  Adjourn

Summary: MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP)   Agenda (Draft)    Centers for D isease Con trol and Prevention  Atlanta, GA     Thursday, September 18, 2025      10:00 AM  Welcome and Roll Call  Dr. Martin Kulldorff (ACIP Chair)   Dr. Mina Zadeh (ACIP Executive Secretary, CDC)      10:30 AM  Update on Work Groups  Dr. Martin Kulldorff (ACIP Chair)       11:00 AM  Measles, Mumps, Rubella, and Varicella  (MMRV) Vaccines     Introduction  Dr. Martin Kulldorff (ACIP Chair)   …